Skip to main content
S 507 112th Congress Senate

Prescription Drug Abuse Prevention and Treatment Act of 2011

Official title: A bill to provide for increased Federal oversight of prescription opioid treatment and assistance to States in reducing opioid abuse, diversion, and deaths.

Introduced: June 28, 2011 See on congress.gov
Health Department of Health and Human ServicesDrug therapyDrug trafficking and controlled substancesDrug, alcohol, tobacco use
More subjectsShow fewer subjects
Executive agency funding and structureHealth facilities and institutionsHealth information and medical recordsHealth personnelHealth programs administration and fundingHealth promotion and preventive carePrescription drugs
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 8, 2011
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Mar 8, 2011
Sponsor introductory remarks on measure. (CR S1408-1409)
Mar 8, 2011
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action March 8, 2011

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Plain-English summary Congressional Research Service

Prescription Drug Abuse Prevention and Treatment Act of 2011 - Amends the Public Health Service Act to direct the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states and nonprofit entities for consumer education about opioid abuse, including methadone abuse.

Amends the Controlled Substances Act to: (1) set forth training requirements for practitioners registered to prescribe or dispense methadone or other opioids; and (2) require each registered opioid treatment clinic to make acceptable arrangements for each patient who is restricted from having a take-home dose of a controlled substance related to treatment to receive a dose of that substance under appropriate supervision when the clinic is closed.

Prohibits any individual or entity (except hospitals that provide direct patient supervision) from prescribing or dispensing a 40-mg diskette of methadone unless such prescription or dispensation is consistent with the current Drug Enforcement Administration (DEA) methadone policy, until the date the Controlled Substances Clinical Standards Commission: (1) publishes dosing guidelines for methadone, and (2) finds that such 40-mg diskettes are safe and clinically appropriate. Requires the Secretary of Health and Human Services (HHS) to establish such Commission to develop and publish guidelines related to methadone use, including safe dosing guidelines for all forms of methadone and benchmark guidelines for the reduction of methadone abuse.

Requires states receiving controlled substances monitoring program grants to: (1) provide information, upon request, to drug enforcement officials relating to an individual who is the subject of an active drug-related investigation; and (2) require opioid-related deaths to be reported to the Administrator.

Directs the Administrator to develop a Model Opioid Treatment Program Mortality Report.

Requires the Administrator to establish and implement, through the National Center for Health Statistics, a National Opioid Death Registry to track opioid-related deaths.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
Cite this page click to expand
APA
U.S. Congress. (2026). S. 507: Prescription Drug Abuse Prevention and Treatment Act of 2011. 112th Congress. Open America. https://openamerica.io/bill/112-S-507/
MLA
"S. 507: Prescription Drug Abuse Prevention and Treatment Act of 2011." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-S-507/.
Bluebook (legal)
S. 507, 112th Cong. (2026), https://openamerica.io/bill/112-S-507/.
Markdown link
[S. 507: Prescription Drug Abuse Prevention and Treatment Act of 2011](https://openamerica.io/bill/112-S-507/)
Report a problem